MaaT Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 19, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	139	111	81	79	132	-
Market Cap Growth	36.09%	36.57%	2.32%	-40.01%	-	-
Enterprise Value	138	97	59	49	123	-
Last Close Price	7.38	7.96	6.98	8.00	13.35	-
PS Ratio	35.41	34.39	36.35	55.35	135.75	-
PB Ratio	16.74	10.70	3.96	2.95	3.31	-
P/TBV Ratio	25.52	12.91	4.24	3.09	3.38	-
EV/Sales Ratio	35.25	30.05	26.41	34.22	126.09	-
Debt / Equity Ratio	1.74	1.54	0.69	0.42	0.15	0.38
Net Debt / Equity Ratio	-0.08	-0.41	-0.50	-0.89	-0.94	-0.87
Net Debt / EBITDA Ratio	0.02	0.15	0.52	1.80	4.30	2.69
Net Debt / FCF Ratio	0.03	0.18	0.52	1.81	4.59	2.25
Asset Turnover	0.08	0.08	0.05	0.03	0.03	-
Inventory Turnover	13.93	12.71	7.41	16.05	-	-
Quick Ratio	2.15	1.81	2.65	4.38	9.93	7.75
Current Ratio	2.22	1.90	2.78	4.57	10.05	7.76
Return on Equity (ROE)	-183.64%	-187.68%	-83.41%	-41.14%	-32.33%	-92.67%
Return on Assets (ROA)	-38.10%	-43.64%	-28.44%	-18.00%	-15.08%	-20.62%
Return on Capital Employed (ROCE)	-92.70%	-118.70%	-63.50%	-38.20%	-19.90%	-24.50%
Earnings Yield	-22.42%	-26.13%	-24.34%	-17.32%	-6.83%	-
FCF Yield	-18.33%	-20.61%	-24.40%	-16.76%	-6.19%	-
Buyback Yield / Dilution	-22.07%	-14.95%	-14.89%	-307.65%	-135.06%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.